Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
R
Radu, Maria
Merck & Co., Inc.
(
W1330-02-11
)
One Drop of Blood, Multiple Sets of Data --- Establishing A Common Protocol for Serotype Specific IGG Concentration Testing Using Mitra® VAMS Dry Blood Samples to Support Vaccine Clinical Studies
Maria Radu
Favorite
Randolph, Theodore
University of Colorado Boulder
(
T1330-01-03
)
Stain-Free Approach to Determine and Monitor Cell Heath Using Supervised and Unsupervised Image-Based Deep Learning
Theodore Randolph
Favorite
(
W1030-02-11
)
Machine Learning Approaches to Analysis of Microscopy Images of Polysorbate Degradation Product Particles
Theodore Randolph
Favorite
(
W1330-01-01
)
Stabilization of Viruses for Vaccines and Gene Therapy by Spray Drying and Lyophilization
Theodore Randolph
Favorite
Rao, V. Ashutosh
US Food and Drug Administration
(
W1030-02-07
)
Comparative Analyses of Thermal Stability Amplifying Peptide Dendrons and Polysorbates
V. Ashutosh Rao
Favorite
Rathore, Anurag
Indian Institute of Technology
(
W1030-02-07
)
Comparative Analyses of Thermal Stability Amplifying Peptide Dendrons and Polysorbates
Anurag Rathore
Favorite
Ren, Bailuo
Boehringer Ingelheim
(
T1230-02-07
)
A Validated Immunocapture LC-MS/MS Hybrid Assay for the Quantitation of a Novel Multi-Domain Therapeutic Protein in Human Plasma with Clinical Sample Analysis
Bailuo Ren
Favorite
Robbie, Joanna
BioAgilytix Labs
(
W1530-02-09
)
Development of Non-Cell Based Potency Assays for Bispecific Antibodies
Joanna Robbie
Favorite
Roberts, Brian
EpiVax, Inc.
(
W1130-02-09
)
Immunogenicity Risk Assessment of Salmon Calcitonin Peptide Impurities Using In Silico and In Vitro Methods
Brian Roberts
Favorite
(
W1230-02-11
)
Comprehensive Assessment of Immunogenicity Risk of Host Cell Proteins in Biologics and Vaccines Using In Silico and In Vitro Methods
Brian Roberts
Favorite
Rodó, Jordi
Svar Life Science AB
(
W1130-02-11
)
Comparison of a Microfluidic Generic Total Antibody (TAb) Assay with Independent Neutralizing Antibody (NAb) and TAb Assays for the Detection of Pre-existing Antibodies against AAV Vectors
Jordi Rodó
Favorite
Rodriguez, Alejandro
Genentech, Inc.
(
T1330-02-09
)
Gyrolab Generic Anti-drug Antibody Assay Streamlines Preclinical Immunogenicity Assessment
Alejandro Rodriguez
Favorite
(
W1130-02-10
)
Choosing the Right Bioanalytical Platform to Accommodate a Biotherapeutic Pharmacokinetic Measurement in Serum and CSF: A Case Study
Alejandro Rodriguez
Favorite
Roos, David
Boehringer Ingelheim
(
T1230-02-07
)
A Validated Immunocapture LC-MS/MS Hybrid Assay for the Quantitation of a Novel Multi-Domain Therapeutic Protein in Human Plasma with Clinical Sample Analysis
David Roos
Favorite
Rosa, Dave
NeuroOne
(
W1430-01-04
)
Innovative Device for Concomitant Therapeutic Compound Delivery into the Brain and Neural Recordings - Feasibility Bench and In Vivo Studies
Dave Rosa
Favorite
Rosenbaum, Anton
AstraZeneca
(
T1130-02-06
)
Biodistribution Analysis of GPC-3 CAR-T Cells in NSG Mice by a Universal ddPCR Assay to Support an IND-Enabling Toxicity Study
Anton Rosenbaum
Favorite
(
W1230-02-09
)
LC-MS FFPE Tissue Analysis Across Multiple Murine Tissues Supports Mouse Relevance for On-Target/Off-Tumor Toxicity Assessment for Anti-STEAP2 CAR-T Therapeutic Development
Anton Rosenbaum
Favorite
Rosenberg, Amy
EpiVax, Inc.
(
T1130-02-11
)
Rapid and Predictive Immunogenicity Risk Assessments Using In Silico Methods
Amy Rosenberg
Favorite
(
W1530-02-10
)
An “I” (Immunogenicity Risk Assessment) for an Eye (Ophthalmology Biologics)
Amy Rosenberg
Favorite
Rutz, Sascha
Genentech, Inc.
(
T1130-02-07
)
Anti-CCR8 Mediated Depletion of Tumor-Infiltrating Regulatory T Cells: Preclinical PK/PD and Translational Strategy in Support of Clinical Development for Solid Tumor Indications
Sascha Rutz
Favorite
